WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS

This group comprises peripherally, centrally and directly acting muscle relaxants.
See also G04BD - Drugs for urinary frequency and incontinence.


M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS

This group comprises centrally acting muscle relaxants. Combined preparations are classified at separate 5th levels using the corresponding 50-series (comb. excl. psycholeptics), or the 70-series (comb. with psycholeptics):
The group is subdivided according to chemical structure.
Combinations with NSAIDs (M01A), analgesics (N02B) or corticosteroids (H02A) are classified here.

These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc.
DDDs for combination products, see list on the website www.whocc.no.


M03BC Ethers, chemically close to antihistamines

Orphenadrine citrate is classified here. Preparations containing orphenadrine chloride are classified in N04AB.
Combinations with e.g. paracetamol are classified in this group at separate 5th levels by using the 50-series.


List of abbreviations

Last updated: 2024-01-26